BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30387148)

  • 21. Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis.
    Wei Y; Kim TJ; Peng DH; Duan D; Gibbons DL; Yamauchi M; Jackson JR; Le Saux CJ; Calhoun C; Peters J; Derynck R; Backes BJ; Chapman HA
    J Clin Invest; 2017 Oct; 127(10):3675-3688. PubMed ID: 28872461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging role of LOXL2 in the promotion of pancreas cancer metastasis.
    Park JS; Lee JH; Lee YS; Kim JK; Dong SM; Yoon DS
    Oncotarget; 2016 Jul; 7(27):42539-42552. PubMed ID: 27285767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human lysyl oxidase-like 2.
    Moon HJ; Finney J; Ronnebaum T; Mure M
    Bioorg Chem; 2014 Dec; 57():231-241. PubMed ID: 25146937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation.
    Iftikhar M; Hurtado P; Bais MV; Wigner N; Stephens DN; Gerstenfeld LC; Trackman PC
    J Biol Chem; 2011 Jan; 286(2):909-18. PubMed ID: 21071451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
    Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
    J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing
    Peng T; Lin S; Meng Y; Gao P; Wu P; Zhi W; Ding W; Cao C; Wu P
    Cell Cycle; 2022 Sep; 21(17):1827-1841. PubMed ID: 35509127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.
    Okada K; Moon HJ; Finney J; Meier A; Mure M
    Biochemistry; 2018 Dec; 57(51):6973-6983. PubMed ID: 30499665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomes from hypoxic endothelial cells have increased collagen crosslinking activity through up-regulation of lysyl oxidase-like 2.
    de Jong OG; van Balkom BW; Gremmels H; Verhaar MC
    J Cell Mol Med; 2016 Feb; 20(2):342-50. PubMed ID: 26612622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization.
    Canesin G; Cuevas EP; Santos V; López-Menéndez C; Moreno-Bueno G; Huang Y; Csiszar K; Portillo F; Peinado H; Lyden D; Cano A
    Oncogene; 2015 Feb; 34(8):951-64. PubMed ID: 24632622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism.
    Vitaliti A; Roccatani I; Iorio E; Perta N; Gismondi A; Chirico M; Pisanu ME; Di Marino D; Canini A; De Luca A; Rossi L
    Cell Oncol (Dordr); 2023 Feb; 46(1):93-115. PubMed ID: 36454513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LOXL2 upregulates hypoxia‑inducible factor‑1α signaling through Snail‑FBP1 axis in hepatocellular carcinoma cells.
    Fan Z; Zheng W; Li H; Wu W; Liu X; Sun Z; Hu H; Du L; Jia Q; Liu Q
    Oncol Rep; 2020 May; 43(5):1641-1649. PubMed ID: 32323822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human peroxidasin 1 promotes angiogenesis through ERK1/2, Akt, and FAK pathways.
    Medfai H; Khalil A; Rousseau A; Nuyens V; Paumann-Page M; Sevcnikar B; Furtmüller PG; Obinger C; Moguilevsky N; Peulen O; Herfs M; Castronovo V; Amri M; Van Antwerpen P; Vanhamme L; Zouaoui Boudjeltia K
    Cardiovasc Res; 2019 Feb; 115(2):463-475. PubMed ID: 29982533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGF-β1-induced SMAD2/3/4 activation promotes RELM-β transcription to modulate the endothelium-mesenchymal transition in human endothelial cells.
    Jiang Y; Zhou X; Hu R; Dai A
    Int J Biochem Cell Biol; 2018 Dec; 105():52-60. PubMed ID: 30120989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition.
    Cuevas EP; Moreno-Bueno G; Canesin G; Santos V; Portillo F; Cano A
    Biol Open; 2014 Feb; 3(2):129-37. PubMed ID: 24414204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolytic processing of lysyl oxidase-like-2 in the extracellular matrix is required for crosslinking of basement membrane collagen IV.
    López-Jiménez AJ; Basak T; Vanacore RM
    J Biol Chem; 2017 Oct; 292(41):16970-16982. PubMed ID: 28864775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jaceosidin, a natural flavone, promotes angiogenesis via activation of VEGFR2/FAK/PI3K/AKT/NF-κB signaling pathways in endothelial cells.
    Lee TH; Jung H; Park KH; Bang MH; Baek NI; Kim J
    Exp Biol Med (Maywood); 2014 Oct; 239(10):1325-34. PubMed ID: 24939823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of N-glycosylation by glucosamine hydrochloride inhibits TGF-β1-induced LOXL2 secretion.
    Kamiya T; Kadowaki M; Atobe T; Kunieda K; Morimoto K; Hara H
    J Cell Biochem; 2023 Jun; 124(6):797-807. PubMed ID: 37062903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.
    Peinado H; Moreno-Bueno G; Hardisson D; Pérez-Gómez E; Santos V; Mendiola M; de Diego JI; Nistal M; Quintanilla M; Portillo F; Cano A
    Cancer Res; 2008 Jun; 68(12):4541-50. PubMed ID: 18559498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin.
    Schmelzer CEH; Heinz A; Troilo H; Lockhart-Cairns MP; Jowitt TA; Marchand MF; Bidault L; Bignon M; Hedtke T; Barret A; McConnell JC; Sherratt MJ; Germain S; Hulmes DJS; Baldock C; Muller L
    FASEB J; 2019 Apr; 33(4):5468-5481. PubMed ID: 30676771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lncRNA GATA6-AS epigenetically regulates endothelial gene expression via interaction with LOXL2.
    Neumann P; Jaé N; Knau A; Glaser SF; Fouani Y; Rossbach O; Krüger M; John D; Bindereif A; Grote P; Boon RA; Dimmeler S
    Nat Commun; 2018 Jan; 9(1):237. PubMed ID: 29339785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.